Progressive Corp (PGR) Financial Statements

Progressive's financial health is highly favourable based on the Quality Indicators framework. The company demonstrates outstanding profitability, with a Return on Invested Capital proxy (ROE) of 37.3%, which far exceeds the 15-20% high-quality threshold. Free cash flow generation is exceptionally strong, with a 14.5% FCF yield indicating high conversion of earnings to cash. The balance sheet is very healthy, supported by a low Debt/Equity ratio of 0.23 and a substantial net cash position implied by the data, comfortably below the Debt/EBITDA < 1.0x benchmark. Revenue growth of 12.2% YoY is consistent and solid. The primary area for monitoring is margin trends; the provided 16.5% operating margin is healthy, but value investors in this cyclical sector should watch for any contraction that could signal heightened competition or claims pressure. The Growth Assessment shows durable, double-digit revenue expansion, though it is below the 20%+ threshold used for high-growth tech companies—this is typical and acceptable for a mature, high-return insurer. The financial profile is one of a profitable, cash-generative company with a conservative capital structure.